Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0880
Source ID: NCT02166359
Associated Drug: Extraneal (Icodextrin)
Title: Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: End Stage Renal Disease
Interventions: DRUG: Extraneal (Icodextrin)|DRUG: Glucose solution
Outcome Measures: Primary: The mean difference and change of triglyceride levels after follow up between 2 groups, The difference and change of triglyceride after follow up between 2 groups (glucose group with diabetes (n=20) vs. icodextrin group with diabetes (n=20) and glucose group without diabetes (n=20) vs. icodextrin group without diabetes (n=20) ), baseline and 3 months after intervention | Secondary: The mean difference and change of erythrocyte membrane monounsaturated fatty acid content and oleic acid content, baseline and 3 months after intervention|The mean difference and change of total cholesterol , LDL, HDL, very low-density lipoprotein, apolipoprotein A and apolipoprotein B, baseline and 3 months after intervention|The mean difference and change of blood glucose level, insulin and HbA1c, baseline and 3 months after intervention|The mean difference and change of ultrafiltration volume, baseline and 3 months after intervention
Sponsor/Collaborators: Sponsor: Dong-A University | Collaborators: Baxter Healthcare Corporation
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 22
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2014-06
Completion Date: 2019-04
Results First Posted:
Last Update Posted: 2019-05-29
Locations: Dong-A University Hospital, Busan, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT02166359